{"id":31366,"date":"2025-04-08T14:53:02","date_gmt":"2025-04-08T06:53:02","guid":{"rendered":"https:\/\/flcube.com\/?p=31366"},"modified":"2025-04-08T14:53:03","modified_gmt":"2025-04-08T06:53:03","slug":"novo-nordisk-partners-with-tencent-healthcare-for-weight-management-initiative-in-china","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=31366","title":{"rendered":"Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China"},"content":{"rendered":"\n<p>In alignment with China&#8217;s &#8220;Weight Management Year&#8221; initiative, Denmark-based Novo Nordisk A\/S (<a href=\"https:\/\/www.google.com\/finance\/quote\/NVO:NYSE\">NYSE: NVO<\/a>) has formed a strategic partnership with Tencent Healthcare. The collaboration aims to develop a comprehensive &#8220;Weight Management Knowledge and Service Zone&#8221; through Tencent&#8217;s Health Mini Program on WeChat and baike.qq.com. This integrated platform will provide the public with accessible tools for understanding healthy weight standards, mastering weight management techniques, and promoting early diagnosis and treatment of obesity.<\/p>\n\n\n\n<p><strong>Collaboration Details<\/strong><br>The partnership will leverage Tencent&#8217;s digital platforms to offer a suite of services, including disease education, health weight assessment, medical mapping, and online appointment functionalities. By integrating these features, Novo Nordisk and Tencent Healthcare seek to enhance public awareness and facilitate scientific weight management practices.<\/p>\n\n\n\n<p><strong>Health Impact<\/strong><br>This initiative underscores Novo Nordisk&#8217;s commitment to improving public health outcomes in China by addressing obesity, a critical risk factor for various chronic diseases. The collaboration is expected to significantly enhance the accessibility of obesity-related diagnostic and treatment services, supporting the early intervention and management of weight-related health issues.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In alignment with China&#8217;s &#8220;Weight Management Year&#8221; initiative, Denmark-based Novo Nordisk A\/S (NYSE: NVO) has&#8230;<\/p>\n","protected":false},"author":1,"featured_media":31368,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[148,860,86,1470],"class_list":["post-31366","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-novo-nordisk","tag-nyse-nvo","tag-obesity","tag-tencent-healthcare"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"In alignment with China&#039;s &quot;Weight Management Year&quot; initiative, Denmark-based Novo Nordisk A\/S (NYSE: NVO) has formed a strategic partnership with Tencent Healthcare. The collaboration aims to develop a comprehensive &quot;Weight Management Knowledge and Service Zone&quot; through Tencent&#039;s Health Mini Program on WeChat and baike.qq.com. This integrated platform will provide the public with accessible tools for understanding healthy weight standards, mastering weight management techniques, and promoting early diagnosis and treatment of obesity.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=31366\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China\" \/>\n<meta property=\"og:description\" content=\"In alignment with China&#039;s &quot;Weight Management Year&quot; initiative, Denmark-based Novo Nordisk A\/S (NYSE: NVO) has formed a strategic partnership with Tencent Healthcare. The collaboration aims to develop a comprehensive &quot;Weight Management Knowledge and Service Zone&quot; through Tencent&#039;s Health Mini Program on WeChat and baike.qq.com. This integrated platform will provide the public with accessible tools for understanding healthy weight standards, mastering weight management techniques, and promoting early diagnosis and treatment of obesity.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=31366\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-08T06:53:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-08T06:53:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0806-png.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"598\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31366#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31366\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China\",\"datePublished\":\"2025-04-08T06:53:02+00:00\",\"dateModified\":\"2025-04-08T06:53:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31366\"},\"wordCount\":192,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31366#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/0806-png.webp\",\"keywords\":[\"Novo Nordisk\",\"NYSE: NVO\",\"Obesity\",\"Tencent Healthcare\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=31366#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31366\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=31366\",\"name\":\"Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31366#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31366#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/0806-png.webp\",\"datePublished\":\"2025-04-08T06:53:02+00:00\",\"dateModified\":\"2025-04-08T06:53:03+00:00\",\"description\":\"In alignment with China's \\\"Weight Management Year\\\" initiative, Denmark-based Novo Nordisk A\\\/S (NYSE: NVO) has formed a strategic partnership with Tencent Healthcare. The collaboration aims to develop a comprehensive \\\"Weight Management Knowledge and Service Zone\\\" through Tencent's Health Mini Program on WeChat and baike.qq.com. This integrated platform will provide the public with accessible tools for understanding healthy weight standards, mastering weight management techniques, and promoting early diagnosis and treatment of obesity.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31366#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=31366\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31366#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/0806-png.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/0806-png.webp\",\"width\":1080,\"height\":598,\"caption\":\"Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=31366#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China - Insight, China&#039;s Pharmaceutical Industry","description":"In alignment with China's \"Weight Management Year\" initiative, Denmark-based Novo Nordisk A\/S (NYSE: NVO) has formed a strategic partnership with Tencent Healthcare. The collaboration aims to develop a comprehensive \"Weight Management Knowledge and Service Zone\" through Tencent's Health Mini Program on WeChat and baike.qq.com. This integrated platform will provide the public with accessible tools for understanding healthy weight standards, mastering weight management techniques, and promoting early diagnosis and treatment of obesity.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=31366","og_locale":"en_US","og_type":"article","og_title":"Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China","og_description":"In alignment with China's \"Weight Management Year\" initiative, Denmark-based Novo Nordisk A\/S (NYSE: NVO) has formed a strategic partnership with Tencent Healthcare. The collaboration aims to develop a comprehensive \"Weight Management Knowledge and Service Zone\" through Tencent's Health Mini Program on WeChat and baike.qq.com. This integrated platform will provide the public with accessible tools for understanding healthy weight standards, mastering weight management techniques, and promoting early diagnosis and treatment of obesity.","og_url":"https:\/\/flcube.com\/?p=31366","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-04-08T06:53:02+00:00","article_modified_time":"2025-04-08T06:53:03+00:00","og_image":[{"width":1080,"height":598,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0806-png.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=31366#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=31366"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China","datePublished":"2025-04-08T06:53:02+00:00","dateModified":"2025-04-08T06:53:03+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=31366"},"wordCount":192,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=31366#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0806-png.webp","keywords":["Novo Nordisk","NYSE: NVO","Obesity","Tencent Healthcare"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=31366#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=31366","url":"https:\/\/flcube.com\/?p=31366","name":"Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=31366#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=31366#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0806-png.webp","datePublished":"2025-04-08T06:53:02+00:00","dateModified":"2025-04-08T06:53:03+00:00","description":"In alignment with China's \"Weight Management Year\" initiative, Denmark-based Novo Nordisk A\/S (NYSE: NVO) has formed a strategic partnership with Tencent Healthcare. The collaboration aims to develop a comprehensive \"Weight Management Knowledge and Service Zone\" through Tencent's Health Mini Program on WeChat and baike.qq.com. This integrated platform will provide the public with accessible tools for understanding healthy weight standards, mastering weight management techniques, and promoting early diagnosis and treatment of obesity.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=31366#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=31366"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=31366#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0806-png.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0806-png.webp","width":1080,"height":598,"caption":"Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=31366#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/04\/0806-png.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=31366"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31366\/revisions"}],"predecessor-version":[{"id":31369,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/31366\/revisions\/31369"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/31368"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=31366"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=31366"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=31366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}